Search
Search Results
##search.searchResults.foundPlural##
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2112PDF: 1159HTML: 3684 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1426PDF: 894HTML: 208 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3556PDF: 1251HTML: 702Figure 2: 423Figure 1: 3089 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
902PDF: 455HTML: 65 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1974PDF: 1460HTML: 259 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2254PDF: 939HTML: 7606Untitled: 254Fig2: 163Fig3: 143Fig4: 162 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2131PDF: 922HTML: 5023Cover Letter: 152Figure 2: 140Figure 1: 150Figure 3: 168Figure 4: 150Figure Legend: 165Table 1: 165Table 2: 160Table 3: 159 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1160PDF: 927HTML: 192 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3463PDF: 1442HTML: 4289CoverLetter: 167Figure1: 176 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3669PDF: 1415HTML: 459Figures . Eliassian: 203 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3999PDF: 1534HTML: 840 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4295PDF: 871HTML: 1299Table1: 165 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2706PDF: 917HTML: 342Preferred Reviewers: 189 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1207PDF: 901HTML: 265Suppl. Figure: 174Suppl. Tables: 189 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3265PDF: 565HTML: 631 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2207PDF: 912HTML: 11106 -
-
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
824PDF: 546HTML: 309 -
-
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1872PDF: 770HTML: 204 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4337PDF: 1872HTML: 17710 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1144PDF: 689HTML: 1203 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7683PDF: 3980HTML: 7290 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5050PDF: 1289HTML: 2725Cover letter: 174 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2006PDF: 917HTML: 128Suppl. Files: 492 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1689PDF: 848HTML: 359Fig1: 212Fig.2: 228Fig. 3: 159Fig. 5: 170Fig. 4: 197 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2080PDF: 848HTML: 302 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3043PDF: 1535HTML: 248 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1348PDF: 901HTML: 290 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1277PDF: 474HTML: 181 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3906PDF: 1269HTML: 2241 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6675PDF: 3555HTML: 724 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1999PDF: 904HTML: 280 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1337PDF: 797HTML: 3103







